BBWI International Growth Accelerates, But Domestic Turnaround Remains Key

What happened

Bath & Body Works' international segment is showing accelerating growth, driven by higher retail sales, store expansion, and strong franchise partnerships, as reported by Zacks. However, this segment contributed only about 4% of total revenue in FY2024, and the company's core North American business continues to struggle with negative comparable sales and margin pressure. The DeepValue Master Report rates BBWI a "WAIT" with a base case value of $24, noting that the new CEO's "Consumer First Formula" transformation may not stabilize sales until 2027. While international momentum is a positive incremental signal, it is not large enough to offset the challenges of declining store traffic, heavy promotions, and share loss to competitors like Ulta and Sephora. The stock trades at a low valuation (6x EPS) but offers limited near-term upside until there is clear evidence of a domestic turnaround.

Implication

Investors should monitor international growth as a potential long-term tailwind, but the investment case hinges on successful execution of the 'Consumer First Formula' and a recovery in North American comps and margins, which may take until 2027 to materialize.

Thesis delta

The article highlights an incremental positive from international, but the overall thesis remains unchanged: BBWI is a wait-and-see turnaround with limited 6-18 month upside and better entry after clearer evidence on comps and margins.